Follow Follow Us
We got you covered. Don’t miss out on the latest news by signing up for our newsletters.
By subscribing, you agree to our Terms of Use and Privacy Policy.
Johnson & Johnson
Taking the dollar up after its initial $2 billion USD offer.
Low levels of the carcinogen were found in several products.
The first batch of doses might be distributed this week in the United States.
Removing products from Neutrogena and Clean & Clear.
